(XLV) Health Care Sector SPDR - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81369Y2090 • Health
XLV: Pharmaceuticals, Equipment, Biotechnology, Services, Technology
The Health Care Select Sector SPDR® Fund (XLV) is designed to track the performance of a specific index, employing a replication strategy to achieve this goal. This means the fund invests substantially all of its assets—specifically at least 95%—in the securities that make up the index it follows. By doing so, it aims to deliver returns that closely mirror the performance of the underlying index.
The fund focuses on companies operating across a broad spectrum of the health care sector. This includes pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology. This diversified exposure allows investors to gain access to a wide range of businesses within the health care industry, from established pharmaceutical giants to innovative biotech firms.
Its important to note that the fund is classified as non-diversified. This means that it can invest a significant portion of its assets in a smaller number of companies or industries, which may lead to higher volatility compared to a diversified fund. Investors should consider this aspect when evaluating the funds potential risks and rewards.
The fund is listed under the ticker symbol XLV on the NYSE ARCA exchange and is categorized as a health care sector ETF. With a market capitalization or assets under management (AUM) of approximately $39.284 billion, it is one of the larger ETFs in its category. The funds focus on the health care sector makes it a popular choice for investors seeking exposure to this industry, which is often driven by factors such as demographic trends, medical innovation, and regulatory changes.
For more information about the fund, including its full holdings, performance data, and other details, investors can visit the official website at http://www.spdrs.com. The fund is domiciled in the United States.
Additional Sources for XLV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XLV ETF Overview
Market Cap in USD | 39,370m |
Category | Health |
TER | 0.09% |
IPO / Inception | 1998-12-16 |
XLV ETF Ratings
Growth 5y | 68.5% |
Fundamental | - |
Dividend | 59.4% |
Rel. Strength Industry | -7.83 |
Analysts | - |
Fair Price Momentum | 147.29 USD |
Fair Price DCF | - |
XLV Dividends
Dividend Yield 12m | 1.58% |
Yield on Cost 5y | 3.04% |
Annual Growth 5y | 6.32% |
Payout Consistency | 96.1% |
XLV Growth Ratios
Growth Correlation 3m | 82.3% |
Growth Correlation 12m | 23.5% |
Growth Correlation 5y | 90.5% |
CAGR 5y | 13.75% |
CAGR/Max DD 5y | 0.86 |
Sharpe Ratio 12m | -0.37 |
Alpha | -6.08 |
Beta | 0.41 |
Volatility | 13.63% |
Current Volume | 8040.8k |
Average Volume 20d | 7819.3k |
As of March 14, 2025, the stock is trading at USD 143.83 with a total of 8,040,826 shares traded.
Over the past week, the price has changed by -3.64%, over one month by -1.75%, over three months by +2.48% and over the past year by -0.24%.
Yes. Based on ValueRay Analyses, Health Care Sector SPDR (NYSE ARCA:XLV) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.51 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XLV as of March 2025 is 147.29. This means that XLV is currently overvalued and has a potential downside of 2.41%.
Health Care Sector SPDR has no consensus analysts rating.
According to ValueRays Forecast Model, XLV Health Care Sector SPDR will be worth about 161.4 in March 2026. The stock is currently trading at 143.83. This means that the stock has a potential upside of +12.2%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 161.4 | 12.2% |